Sunrest Lifescie

{
  "main_header": {
    "sid": 10039076,
    "name": "Sunrest Lifescie",
    "stock_name": "Sunrest Lifescie",
    "full_name": "Sunrest Lifescience Ltd",
    "name_url": "stocks-analysis/sunrest-lifescie",
    "exchange": 1,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "32.10",
    "chg": -0.4,
    "chgp": "-1.23%",
    "dir": -1,
    "prev_price": "32.50",
    "mcapval": "14.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "SUNREST",
    "ind_name": "Healthcare Services",
    "ind_code": 49,
    "indexname": "",
    "isin": "INE0PLZ01012",
    "curr_date": "Jan 19",
    "curr_time": "",
    "bse_nse_vol": 16000,
    "exc_status": "Active",
    "traded_date": "Jan 19, 2026",
    "traded_date_str": "2026 01 19",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/sunrest-lifescie-10039076-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is Sunrest Lifescie overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-sunrest-lifescie-overvalued-or-undervalued-3709955",
        "imagepath": "",
        "date": "2025-11-18 08:25:31",
        "description": "As of 17 November 2025, Sunrest Lifescie has moved from a fair to an attractive valuation grade. The company is currently considered undervalued, especially when compared to its peers. Key ratios include a PE ratio of 9.87, an EV to EBITDA of 8.54, and a PEG ratio of 0.01, indicating strong potential for growth relative to its price.\n\nIn comparison to its peers, Sunrest Lifescie stands out with a significantly lower PE ratio than Elitecon International, which is very expensive at 294.38, and MMTC, which has a PE of 139.7. Additionally, PTC India, categorized as very attractive, has a PE of 7.56, further emphasizing Sunrest Lifescie's favorable valuation position. Despite recent stock performance lagging behind the Sensex, with a year-to-date return of -10.68% versus the Sensex's 10.02%, the underlying financial metrics suggest that Sunrest Lifescie presents a compelling investment opportunity...."
      },
      {
        "title": "How has been the historical performance of Sunrest Lifescie?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-sunrest-lifescie-3699813",
        "imagepath": "",
        "date": "2025-11-13 23:51:33",
        "description": "Answer:\nThe historical performance of Sunrest Lifescie shows a consolidated net profit of 2.01 crore for the year ending March 2025, with net sales amounting to 33.41 crore. The total operating income for the same period was also 33.41 crore, while total expenditure, excluding depreciation, was 30.39 crore, resulting in an operating profit (PBDIT) of 3.02 crore. The profit before tax stood at 2.62 crore, leading to a profit after tax of 2.01 crore after accounting for tax expenses of 0.61 crore. The earnings per share (EPS) were reported at 4.69, with a PAT margin of 6.02%. \n\nIn terms of balance sheet metrics, the total assets of Sunrest Lifescie reached 35.13 crore, with total liabilities also at 35.13 crore, indicating a balanced position. The company’s shareholder's funds increased to 16.19 crore, up from 14.19 crore in the previous year. Long-term borrowings rose to 4.08 crore, while total debt remained..."
      },
      {
        "title": "Why is Sunrest Lifescie falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-sunrest-lifescie-fallingrising-3645224",
        "imagepath": "",
        "date": "2025-10-25 00:14:03",
        "description": "As of 24-Oct, Sunrest Lifescience Ltd is experiencing a decline in its stock price, currently at Rs 42.00, which reflects a decrease of Rs 2.5 or 5.62%. The stock has underperformed significantly, with a 1-week return of -7.69% and a year-to-date decline of -18.45%. It is currently trading lower than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Additionally, the stock is close to its 52-week low, being only 4.4% away from Rs 40.15. However, there has been a notable increase in investor participation, with delivery volume rising by 250% against the 5-day average, suggesting some interest despite the overall negative performance.\n\nIn the broader market context, the Sensex has shown a positive return of +0.33% over the past week, contrasting sharply with Sunrest Lifescience's decline. This indicates that the stock is not only underperforming relative to the marke..."
      }
    ],
    "total": 86,
    "sid": "10039076",
    "stock_news_url": "https://www.marketsmojo.com/news/sunrest-lifescience-10039076"
  },
  "announcements": "",
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Is Sunrest Lifescie overvalued or undervalued?

2025-11-18 08:25:31

As of 17 November 2025, Sunrest Lifescie has moved from a fair to an attractive valuation grade. The company is currently considered undervalued, especially when compared to its peers. Key ratios include a PE ratio of 9.87, an EV to EBITDA of 8.54, and a PEG ratio of 0.01, indicating strong potential for growth relative to its price. In comparison to its peers, Sunrest Lifescie stands out with a significantly lower PE ratio than Elitecon International, which is very expensive at 294.38, and MMTC, which has a PE of 139.7. Additionally, PTC India, categorized as very attractive, has a PE of 7.56, further emphasizing Sunrest Lifescie's favorable valuation position. Despite recent stock performance lagging behind the Sensex, with a year-to-date return of -10.68% versus the Sensex's 10.02%, the underlying financial metrics suggest that Sunrest Lifescie presents a compelling investment opportunity....

Read full news article

How has been the historical performance of Sunrest Lifescie?

2025-11-13 23:51:33

Answer: The historical performance of Sunrest Lifescie shows a consolidated net profit of 2.01 crore for the year ending March 2025, with net sales amounting to 33.41 crore. The total operating income for the same period was also 33.41 crore, while total expenditure, excluding depreciation, was 30.39 crore, resulting in an operating profit (PBDIT) of 3.02 crore. The profit before tax stood at 2.62 crore, leading to a profit after tax of 2.01 crore after accounting for tax expenses of 0.61 crore. The earnings per share (EPS) were reported at 4.69, with a PAT margin of 6.02%. In terms of balance sheet metrics, the total assets of Sunrest Lifescie reached 35.13 crore, with total liabilities also at 35.13 crore, indicating a balanced position. The company’s shareholder's funds increased to 16.19 crore, up from 14.19 crore in the previous year. Long-term borrowings rose to 4.08 crore, while total debt remained...

Read full news article

Why is Sunrest Lifescie falling/rising?

2025-10-25 00:14:03

As of 24-Oct, Sunrest Lifescience Ltd is experiencing a decline in its stock price, currently at Rs 42.00, which reflects a decrease of Rs 2.5 or 5.62%. The stock has underperformed significantly, with a 1-week return of -7.69% and a year-to-date decline of -18.45%. It is currently trading lower than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Additionally, the stock is close to its 52-week low, being only 4.4% away from Rs 40.15. However, there has been a notable increase in investor participation, with delivery volume rising by 250% against the 5-day average, suggesting some interest despite the overall negative performance. In the broader market context, the Sensex has shown a positive return of +0.33% over the past week, contrasting sharply with Sunrest Lifescience's decline. This indicates that the stock is not only underperforming relative to the marke...

Read full news article

View All News